Clinical Trial Update: Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST [Phase 3]

View source ↗

Summary

Phase 3 dose-ranging study evaluating the safety and efficacy of a fixed-dose combination of extended-release niacin and simvastatin in adults with hypercholest…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Niacin ER (extended-release niacin) (niacin (extended-release))
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Kos Pharmaceuticals | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED